ORDITURA, Michele
 Distribuzione geografica
Continente #
EU - Europa 4.280
NA - Nord America 3.648
AS - Asia 726
AF - Africa 19
SA - Sud America 14
OC - Oceania 10
Continente sconosciuto - Info sul continente non disponibili 7
Totale 8.704
Nazione #
US - Stati Uniti d'America 3.571
IE - Irlanda 1.386
UA - Ucraina 625
IT - Italia 613
GB - Regno Unito 471
DE - Germania 368
FR - Francia 321
CN - Cina 273
SG - Singapore 213
FI - Finlandia 161
SE - Svezia 142
GR - Grecia 117
KR - Corea 93
TR - Turchia 89
CA - Canada 70
VN - Vietnam 38
PL - Polonia 30
BE - Belgio 16
SC - Seychelles 13
CZ - Repubblica Ceca 10
JP - Giappone 7
MX - Messico 7
NL - Olanda 7
EU - Europa 6
NZ - Nuova Zelanda 6
ES - Italia 5
AU - Australia 4
BR - Brasile 4
IR - Iran 4
CO - Colombia 3
EG - Egitto 3
PE - Perù 3
BD - Bangladesh 2
CH - Svizzera 2
CL - Cile 2
PK - Pakistan 2
A1 - Anonimo 1
AL - Albania 1
AR - Argentina 1
HK - Hong Kong 1
IL - Israele 1
IN - India 1
LK - Sri Lanka 1
LU - Lussemburgo 1
MA - Marocco 1
PT - Portogallo 1
PY - Paraguay 1
RO - Romania 1
RS - Serbia 1
RU - Federazione Russa 1
TH - Thailandia 1
TN - Tunisia 1
ZA - Sudafrica 1
Totale 8.704
Città #
Dublin 1.376
Jacksonville 935
Chandler 645
Princeton 190
Medford 172
Caserta 138
Singapore 131
Bremen 122
New York 120
Roxbury 120
Ann Arbor 107
Boardman 103
San Mateo 95
Naples 78
Wilmington 76
Seoul 71
Woodbridge 59
Elora 52
Nanjing 46
Des Moines 45
Beijing 44
Napoli 41
Dong Ket 36
Cambridge 34
Jinan 31
Kraków 29
Ashburn 25
Los Angeles 21
Mountain View 20
Houston 18
Brussels 15
Norwalk 15
Aiello Del Sabato 14
Helsinki 14
Munich 13
Nanchang 13
Shenyang 11
Auburn Hills 10
Brno 10
Ottawa 10
Changsha 9
Tianjin 9
Düsseldorf 8
Hangzhou 8
Redwood City 8
Lappeenranta 7
Milan 7
Ningbo 7
Taizhou 7
Lanzhou 6
Salerno 6
Shanghai 6
Zhengzhou 6
Guangzhou 5
Hebei 5
Jiaxing 5
Kunming 5
Taiyuan 5
Toronto 5
Battipaglia 4
Boydton 4
Changchun 4
Haikou 4
Marigliano 4
Rome 4
San Nicola la Strada 4
Scottsdale 4
Somma Vesuviana 4
Trieste 4
Arzignano 3
Aversa 3
Benevento 3
Bogotá 3
Canicattì 3
Casoria 3
Catania 3
Cattolica 3
Ercolano 3
Frattamaggiore 3
Gunzenhausen 3
Hanover 3
Jesi 3
Lima 3
Maynooth 3
Mugnano Di Napoli 3
Padova 3
Parma 3
Pomezia 3
Walnut 3
Xiangfen 3
Amsterdam 2
Andover 2
Antea 2
Athens 2
Avellino 2
Bagnoli Irpino 2
Barcelona 2
Bari 2
Buonabitacolo 2
Calvizzano 2
Totale 5.352
Nome #
ONCOLOGIA MEDICA 145
Safety and efficacy of sorafenib in patients with advanced hepatocellular carcinoma and Child-Pugh A or B cirrhosis 102
Adjuvant anastrozole versus exemestane versus letrozole, upfront or after 2 years of tamoxifen, in endocrine-sensitive breast cancer (FATA-GIM3): a randomised, phase 3 trial 90
Adjuvant zoledronic acid and letrozole plus ovarian function suppression in premenopausal breast cancer: HOBOE phase 3 randomised trial 87
Neutrophil to lymphocyte ratio (NLR) for prediction of distant metastasis-free survival (DMFS) in early breast cancer: A propensity score-matched analysis 85
Effect of preoperative chemoradiotherapy on outcome of patients with locally advanced esophagogastric junction adenocarcinoma—a pilot study. Curr Oncol 21, 3, june 2014 125-133 82
Anti-epidermal growth factor receptor monoclonal antibodies in cancer therapy. 79
Amifostine: a selective cytoprotective agent of normal tissues from chemo-radiotherapy induced toxicity (Review) 77
Elevated perioperative serum vascular endothelial growth factor levels in patients with colon carcinoma. 76
Pancreatic fistula following pancreatoduodenectomy. Evaluation of different surgical approaches in the management of pancreatic stump. Literature review. 74
Modified versus standard D2 lymphadenectomy in total gastrectomy for nonjunctional gastric carcinoma with lymph node metastasis 73
Hepatoid carcinoma colliding with a liposarcoma of the left colon serosa presenting as an abdominal mass 73
Serum insulin-like growth factor 1 correlates with the risk of nodal metastasis in endocrine-positive breast cancer 72
A multicenter phase II study of induction chemotherapy with FOLFOX-4 and cetuximab followed by radiation and cetuximab in locally advanced oesophageal cancer 72
Clinical management of advanced gastric cancer: Role of new molecular drugs. 71
Antitumor activity of bortezomib in human cancer cells with acquired resistance to anti-epidermal growth factor receptor tyrosine kinase inhibitors 71
TRASTUZUMAB RESISTANCE IN BREAST CANCER 71
Farmacogenomica e cancro colorettale 68
Conservative management and parenchyma-sparing resections of pancreatic neuroendocrine tumors: Literature review. 68
Adjuvant chemotherapy with epirubicin, leucovorin, 5-fluorouracil and etoposide regimen in resected gastric cancer patients: a randomized phase III trial by the Gruppo Oncologico Italia Meridionale (GOIM 9602 Study) 66
Adjuvant chemoradiotherapy in patients with stage III-IV radically resected gastric cancer: a pilot study 66
CD 26-positive/CD 326-negative circulating cancer cells as prognostic markers for colorectal cancer recurrence 66
Combined CD133/CD44 Expression as a Prognostic Indicator of Disease-Free Survival in Patients With Colorectal Cancer. 66
Circulating levels of interleukin-10 and interleukin-6 in gastric and colon cancer patients before and after surgery: relationship with radicality and outcome 65
Treatment of gastric cancer. 64
Phosphatidylinositol 3-kinase (PI3Ka)/AKT axis blockade with taselisib or ipatasertib enhances the efficacy of anti-microtubule drugs in human breast cancer cells 63
A phase II study of biweekly oxaliplatin plus infusional 5-fluorouracil and folinic acid (FOLFOX-4) as first-line treatment of advanced gastric cancer patients 62
Different Biomarkers address different colorectal cancer stem cell populations: who's the killer? 62
Behaviour of interleukin-2 serum levels in advanced non-small-cell lung cancer patients: relationship with response to therapy and survival 62
Sequence-dependent antiproliferative effects of cytotoxic drugs and epidermal growth factor receptor inhibitors 61
Chemoradiotherapy as adjuvant treatment of gastric cancer 61
Cetuximab, a chimeric human mouse anti-epidermal growth factor receptor monoclonal antibody, in the treatment of human colorectal cancer 61
Naples Prognostic Score, Based on Nutritional and Inflammatory Status, is an Independent Predictor of Long-term Outcome in Patients Undergoing Surgery for Colorectal Cancer 61
Vertebral carcinomatosis eleven years after advanced gastric cancer resection: A case report. 60
Cardiotossicità da antracicline: attualità e prospettive 60
Antitumor activity of sorafenib in human cancer cell lines with acquired resistance to EGFR and VEGFR tyrosine kinase inhibitors. 60
Behavior of circulating CD4+CD25+FOXP3* regulatory T cells in colon cancer patients undergoing surgery 60
Comprehensive genome profiling by next generation sequencing of circulating tumor DNA in solid tumors: a single academic institution experience 59
The lymph node ratio is a powerful prognostic factor of node-positive colon cancers undergoing potentially curative surgery. 58
Synergistic Antitumor Activity of Sorafenib in Combination with Epidermal Growth Factor Receptor Inhibitors in Colorectal and Lung Cancer Cells 58
Interleukin-6 serum level correlates with survival in advanced gastrointestinal cancer patients but is not an independent prognostic indicator 58
Anthracycline-induced cardiotoxicity: monitoring and prevention of the lesion 58
Clinical outcome and molecular characterisation of chemorefractory metastatic colorectal cancer patients with long-term efficacy of regorafenib treatment 58
The over-the-scope-clip (OTSC) system is effective in the treatment of chronic esophago-jejunal anastomotic leakage 58
Comparison of the current AJCC-TNM numeric-based with a new anatomical location-based lymph node staging system for gastric cancer: A western experience 58
Indocyanine Green Fluorescence Imaging-Guided Surgery in Primary and Metastatic Liver Tumors 58
Fluorescence-Guided Surgery in the Combined Treatment of Peritoneal Carcinomatosis from Colorectal Cancer: Preliminary Results and Considerations 58
Determination of molecular marker expression can predict clinical outcome in colon carcinomas 57
Post- operative xelox and chemoradiation in stage III-IV radically resected gastric cancer patients: preliminary results of a pilot study. 57
Capecitabine plus weekly oxaliplatin in gastrointestinal tumors. A phase I study 56
Ventricular repolarization time indexes following anthracycline treatment 56
Clinical activity of FOLFIRI plus cetuximab according to extended gene mutation status by next generation sequencing: findings from the CAPRI-GOIM trial. 55
Integrated therapy in localized gastric cancer: targeted and tailored approach. 55
Prognostic significance of circulating IL-10 and IL-6 serum levels in colon cancer patients undergoing surgery 55
A possible connective tissue primary lymphoepithelioma-like carcinoma (LELC). 55
Analysis of recovery time indexes in 5-fluorouracil-treated cancer patients 55
Il linfoma primitivo della parotide: una localizzazione infrequente 55
Adult Wilms' tumor: a case report 55
Pegylated liposomal doxorubicin: pharmacologic and clinical evidence of potent antitumor activity with reduced anthracyclina-induced cardiotoxicity (review) 55
Il trattamento delle neoplasie polmonari nell’anziano 55
Conversion chemotherapy followed by epatic resection in colorectal cancer with initially unresectable liver-limited metastases 55
Complete response to preoperative chemoradiation and survival in esophageal cancer : a pooled analysis of three singe-institution phase II trials. 55
Serum interleukin-10 is an independent prognostic factor in advanced solid tumors 54
Neo-adjuvant and adjuvant chemotherapy of gastric cancer 54
Neutrophil to lymphocyte ratio is a strong predictor of tumor recurrence in early colon cancers: a propensity score-matched analysis 54
Clinical activity and tolerability of FOLFIRI and cetuximab in elderly patients with metastatic colorectal cancer in the CAPRI-GOIM first-line trial 54
Serum interleukin-10 levels in patients with advanced gastrointestinal malignancies 53
A true splenic cyst producing carbohydrate antigen 19-9 and cancer antigens 50 and 125, but not interleukin 10 53
Weekly docetaxel and capecitabine is not effective in the treatment of advanced gastric cancer: A phase II study 53
Carcinoma dell'esofago 53
Targeting EGFR in Pancreatic Cancer Treatment. 53
Metachronous Gastrointestinal Stromal Tumors (Gists) or relapse of the primary tumor ? A challenging case of multiple Gists in an elderly patient 53
Three dimensional primary cultures for selecting human breast cancers that are sensitive to the anti-tumor activity of ipatasertib or taselisib in combination with anti-microtubule cytotoxic drugs 53
Serum vascular endothelial growth factor (VEGF)levels correlate with tumor VEGF and p53 overexpression in endocrine positive primary breast cancer 52
Cetuximab in the treatment of colorectal cancer. 52
Epidermal growth factor receptor (EGFR) expression is associated with a worse prognosis in gastric cancer patients undergoing curative surgery 51
Correlation between efficacy and skin rash occurrence following treatment with the epidermal growth factor receptor inhibitor cetuximab: a single institution retrospective analysis 51
Elevated serum levels of interleukin-8 in advanced non-small cell lung cancer patients: Relationship with prognosis 51
Activity and molecular targets of pioglitazone via blockade of proliferation, invasiveness and bioenergetics in human NSCLC 51
Preoperative chemo-radiotherapy for carcinoma of the esophagus 50
Novel investigational drugs for gastric cancer 50
Serum interleukin-10 levels as a prognostic factor in advanced non-small cell lung cancer patients 50
Propensity score-matched comparison between complete mesocolic excision and classic right hemicolectomy for colon cancer 50
Perioperative Treatment in Resectable Gastric Cancer: Current Perspectives and Future Directions 50
Addition of either irinotecan or methotrexate to bolus 5-fluorouracil and high-dose folinic acid every 2 weeks in advanced colorectal carcinoma: A randomised study by the Southern Italy Cooperative Oncology Group 49
Prognostic value of p27, p53, and vascular endothelial growth factor in Dukes’ A and B colon cancer patients undergoing potentially curative surgery 49
Atypycal presentation of Merkel cell carcinoma positive to polyomavirus DNA detection: experience from a single center 49
Adjuvant chemotherapy of gastric cancer: which regimen? 48
The new European gold standard treatment for rectum cancer 48
Detection of erbB2 copy number variations in plasma of patients with esophageal carcinoma 48
Interaction between the epidermal growth factor receptor (EGFR) and the vascular endothelial growth factor (VEGF) pathways: a rational approach for multi-target anticancer therapy 48
Emergenze ematologiche nel paziente neoplastico 48
Pancreatic neuroendocrine tumors: Nosography, management and treatment 48
Weekly chemotherapy with cisplatin and paclitaxel and concurrent radiation therapy as preoperative treatment in locally advanced esophageal cancer: A phase II study 47
Inflammatory and nutritional status is a predictor of long-term outcome in patients undergoing surgery for gastric cancer. Validation of the Naples prognostic score. 47
Liquid Biopsy at Home: Delivering Precision Medicine for Patients with Cancer During the Covid-19 Pandemic 47
Is complete mesocolic excision with central vascular ligation safe and effective in the surgical treatment of right-sided colon cancers ? A prospective study. 46
Impact of total fundoplication on esophageal transit: analysis by combined multichannel intraluminal impedance and manometry. 46
MEK inhibitor as a single agent and in combination with everolimus or sorafenib in a panel of colorectal cancer cell lines: implication for multitargeted approach 46
Beyond bevacizumab: new anti-VEGF strategies in colorectal cancer. 46
Totale 5.979
Categoria #
all - tutte 39.543
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 39.543


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/2020714 0 0 0 14 156 28 210 81 91 61 49 24
2020/20211.387 128 17 153 85 257 16 196 141 13 165 146 70
2021/20221.171 104 3 17 19 412 7 19 39 42 55 114 340
2022/20232.682 321 45 37 206 305 207 15 159 1.290 11 45 41
2023/20241.005 85 33 48 85 351 127 9 21 10 18 65 153
2024/2025159 22 94 40 3 0 0 0 0 0 0 0 0
Totale 9.223